secwatch.observer — SEC 8-K summary
======================================

Issuer:     Catheter Precision, Inc. (VTAK)
CIK:        0001716621
Form:       8-K
Filed at:   2023-06-05T23:59:59+00:00
Accession:  0001654954-23-007595
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ra Medical Q1 net loss $66.4M, goodwill impaired $56.1M; revenue $85K
---------------------------------------------------------------------

- Revenue of $85K vs $9K YoY; net loss $66.4M includes $56.1M goodwill impairment.
- Cash used in operations $12.1M, incl. $5M DOJ settlement payment; cash $12.2M at Mar 31.
- Acquisition of Catheter Precision closed Jan 2023; $8M financing obtained in March.
- CEO Will McGuire resigned; David Jenkins named Interim CEO; Steve Passey appointed CFO.
- VIVO system launch underway with five direct sales reps; LockeT closure device introduced.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716621/000165495423007595/0001654954-23-007595-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716621/000165495423007595/rmed_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-007595

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer